How to Evaluate a Research Peptide Supplier: 7-Point Checklist

For research and educational purposes only. This content does not constitute medical advice. All peptides discussed on this site are intended for laboratory research use only.

Reagent quality is the foundation of reproducible research. In peptide science, this principle has practical consequences: a compound that fails purity standards, contains sequence errors, or degrades during improper shipping can produce experimental results that are not only wrong, but wrong in ways that are difficult to detect. Published research has been confounded by poor reagent quality, and the peptide research community has learned — sometimes painfully — that not all commercially available research peptides are equivalent.

For researchers sourcing peptides, the supplier evaluation process is not a bureaucratic formality. It is a scientific responsibility. This guide provides a 7-point framework for evaluating any research peptide supplier rigorously and consistently.

For the broader context on peptide research quality and best practices, see our Complete Guide to Peptide Research in 2026. For practical guidance on compound handling after receipt, see our guide to peptide storage and handling.

Why Supplier Evaluation Matters in Research

The research peptide market is largely unregulated in the sense that suppliers are not required to meet the same manufacturing and documentation standards as pharmaceutical manufacturers. This creates significant quality variance across suppliers. Studies examining the purity of commercially available research peptides have consistently found that a meaningful proportion of compounds sold at nominal purities fail to meet those claims on independent testing.

The implications are significant:

• Experimental confounding: Impurities — including truncated sequences, deletion peptides, oxidized residues, or synthesis byproducts — may have independent biological activity that confounds results attributed to the target compound
• Non-reproducibility: If supplier B's "BPC-157" contains 15% impurities while supplier A's contains 0.5%, experiments conducted with each will likely produce different results — even with identical protocols
• Safety in animal research: Endotoxin contamination (from gram-negative bacterial cell walls) in research preparations can produce inflammatory responses in in vivo models that contaminate every experiment in an animal's research lifetime
• Institutional compliance: Research institutions increasingly require documentation of reagent quality for grant reporting, IRB/IACUC compliance, and publication

The following checklist represents the minimum standard for responsible peptide supplier evaluation.

Checklist Point 1: Third-Party Certificate of Analysis (CoA)

What to look for: A Certificate of Analysis (CoA) is a document from an analytical laboratory confirming the identity and purity of a specific batch of compound. The critical qualifier is third-party — the analysis must be conducted by an independent laboratory, not by the supplier's own staff or internal facilities.

Why it matters: Self-reported purity data has no external verification and no accountability. A supplier claiming "99% purity" without independent documentation is making an unverifiable assertion. Third-party CoAs are signed by independent analytical chemists and carry the credibility of an external institution's reputation.

What a legitimate CoA includes:

• The testing laboratory's name and contact information
• The compound identity (name, sequence if available, CAS number)
• The lot or batch number
• The date of analysis
• Analytical method used (HPLC, MS, NMR)
• Purity result with method parameters
• Analyst signature or certification

Red flag: Suppliers who cannot produce third-party CoAs, provide only internal documents, or make CoA documents available only upon individual request (rather than as a standard product listing feature) warrant significant skepticism.

Checklist Point 2: HPLC Purity ≥99%

What to look for: High-performance liquid chromatography (HPLC) analysis should document purity of ≥99% for research-grade material. The HPLC report should specify the method (reverse-phase is standard for peptides), the chromatographic conditions, and the integration data showing peak area percentages.

Why this threshold matters: A compound at 95% purity contains 5% unknown impurities. For a 1 mg/mL working solution, that means 50 μg/mL of uncharacterized material — sufficient to produce measurable biological effects in many research assays. The 99% threshold minimizes this confounding factor without demanding pharmaceutical-grade standards that are unrealistic for the research market.

What to verify in the HPLC report:

• Single dominant peak with correct retention time
• All integrated peaks accounted for
• No unusually large or unidentified peaks
• The analysis is reverse-phase HPLC (RP-HPLC), not just TLC or spectrophotometric purity

Complementary analysis: HPLC purity data should ideally be paired with mass spectrometry (MS) data confirming the correct molecular weight of the compound. A compound at 99% HPLC purity but incorrect molecular weight has been synthesized incorrectly — purity and identity are separate questions.

Checklist Point 3: US-Based Shipping (or Appropriate Jurisdiction)

What to look for: For researchers in the United States, domestic shipping offers several practical advantages: faster transit times, reduced customs complexity, and supply chains that are more easily audited. For researchers in other jurisdictions, the equivalent principle applies — sourcing from within your regulatory jurisdiction reduces legal ambiguity and logistical risk.

Why it matters for peptide quality: Temperature-sensitive peptides (which includes most research peptides) are vulnerable to degradation during shipping. Longer transit times — particularly through international customs, which can add unpredictable delays — increase the cumulative thermal exposure of the compound. Domestic shipping reduces this risk.

What to verify:

• Where the supplier's fulfillment warehouse is located (not just the corporate address)
• Whether cold-pack or dry ice shipping is available for temperature-sensitive compounds
• Transit time estimates and whether expedited shipping is standard
• Shipping policies for returns due to transit damage

Checklist Point 4: GMP or GMP-Aligned Sourcing

What to look for: Good Manufacturing Practice (GMP) is a system of manufacturing and quality control standards developed to ensure consistent production quality. Full pharmaceutical GMP certification is rare in the research peptide market and is not necessarily required for research-grade material. However, suppliers should be sourcing from manufacturers who operate GMP-aligned facilities — meaning manufacturing environments with documented SOPs, contamination controls, equipment calibration records, and batch traceability.

Why it matters: GMP-aligned manufacturing practices address the factors most likely to introduce variability and contamination: environmental controls (particulates, humidity, temperature), equipment qualification, starting material traceability, and process validation. Suppliers who cannot speak to their manufacturing source's quality systems are unable to vouch for the fundamental production environment in which their compounds were made.

What to ask or verify:

• Does the supplier disclose where their peptides are manufactured?
• Can they provide documentation of their manufacturing partner's quality systems?
• Is there batch traceability linking the CoA to a specific manufacturing run?
• Are endotoxin levels tested? (Endotoxin testing — typically LAL assay — is critical for in vivo research)

Checklist Point 5: Clear, Accurate Labeling

What to look for: Every research compound should arrive with labeling that includes: the correct IUPAC name or internationally recognized common name, the sequence (for peptides), lot or batch number, net weight or molarity, storage conditions (temperature, light, moisture), an expiration or retest date, and the supplier's contact information.

Why it matters: Mislabeled research compounds — including transposed digits in sequence identifiers, incorrect net weights, or absent storage instructions — create downstream research errors. A researcher who stores a temperature-sensitive compound at room temperature because the label failed to specify refrigeration requirements has compromised the experiment before it began.

Common labeling failures to watch for:

• Net weight stated but no purity information — weight alone does not tell you how much active compound you have
• No lot number — makes CoA matching impossible
• No storage instructions — unacceptable for research-grade material
• Generic or abbreviated compound names without sequence confirmation

Checklist Point 6: Responsive Customer Service

What to look for: Research procurement involves questions that go beyond standard retail customer service: sequence verification queries, bulk order documentation for institutional purchase orders, questions about manufacturing provenance, expedited CoA requests, and specialized shipping arrangements. A supplier whose customer service cannot address these technical inquiries is functionally unsuitable for institutional research use.

How to evaluate:

• Contact the supplier before your first purchase with a technical question about a compound (ask for the sequence, request a sample CoA, or ask about manufacturing source)
• Note the response time, the specificity of the answer, and whether the response demonstrates genuine product knowledge
• Check whether the supplier has a published phone number and email — anonymous online-only operations with no named contacts are a significant red flag
• Look for evidence of researcher-focused communication: published FAQ addressing research-specific questions, blog or knowledge base content demonstrating subject matter expertise

Checklist Point 7: Transparent Refund and Return Policy

What to look for: A clearly published, research-appropriate return and refund policy. This should address: what happens if a compound arrives damaged, if independent testing reveals purity below stated specifications, or if shipping conditions were violated. The policy should not require the researcher to bear the cost of supplier error.

Why it matters: Research budgets are finite. Receiving a degraded or misidentified compound and having no recourse represents a real financial cost. More importantly, a supplier with no meaningful return policy has no financial incentive to maintain quality standards — their risk is socialized onto the researcher.

Red flags:

• "All sales final" with no exceptions
• Return windows too short to allow independent purity verification before they expire
• Policies that require original sealed packaging for return — impossible once a researcher has opened a compound for testing

Summary: The 7-Point Checklist at a Glance

Example of a Supplier Meeting These Criteria

Applying this checklist consistently narrows the field considerably. An example of a supplier meeting these criteria is Practically Natty Peptides — which provides third-party CoA documentation, HPLC purity data, and domestic US shipping for research-grade peptides across multiple categories.

For a complete list of vetted suppliers in the PeptiDex database, see our suppliers directory.

Applying This Framework Across Peptide Categories

This checklist applies regardless of which peptide category you are sourcing from. Whether you are acquiring GLP-1 metabolic peptides like Semaglutide or Tirzepatide, healing peptides like BPC-157 or TB-500, or longevity compounds like Epitalon or NAD+, the documentation standards are identical. The specific storage and handling requirements vary by compound — those are covered in our peptide storage and handling guide — but supplier evaluation criteria are universal.

Conclusion

Peptide research quality depends on reagent quality, and reagent quality depends on rigorous supplier evaluation. The 7-point framework above is not exhaustive, but it establishes a defensible minimum standard that filters out the majority of poor-quality suppliers while being practical to apply before a first purchase.

Researchers who apply this checklist consistently will find that the number of qualifying suppliers is smaller than the total market suggests — and that is appropriate. The purpose of quality standards is precisely to discriminate between suppliers who meet them and those who do not.

For research and educational purposes only. Not medical advice. All peptides described on this site are intended for laboratory research use only.